ClinicalTrials.Veeva

Menu

Peppermint Oil for Urinary Retention

TriHealth logo

TriHealth

Status

Terminated

Conditions

Urinary Retention

Treatments

Other: Peppermint oil vapors
Other: Mineral Oil

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

A randomized controlled study will be conducted, with two arms. Postpartum women experiencing urinary retention will be randomized into one of the two following arms:

  • Arm 1: Subjects will be exposed to vapor of peppermint oil
  • Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.

Full description

The purpose of the study is to determine if the use of peppermint oil among postpartum women experiencing urinary retention will increase spontaneous urination and decrease the need for catheterization. A randomized controlled study will be conducted, with two arms. Subjects will be randomized into one of the two following arms:

  • Arm 1: Subjects will be exposed to vapor of peppermint oil
  • Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.

Enrollment

17 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 1. 18 years old or older 2. English speaking 3. Admitted to Bethesda North Mom Baby Unit 4. Postpartum 5. Experiencing urinary retention - defined as meeting at least one of the following criteria:

    • More than 6 hours after delivery or foley catheter removal without being able to spontaneously void
    • Symptomatic urinary retention without being able to spontaneously void
    • Change in fundal height or position without being able to spontaneously void 6. Bladder scan showing bladder containing 400mL or more urine

Exclusion criteria

  1. Allergy to peppermint
  2. Asthma
  3. Active herpes lesions
  4. Seizure disorder
  5. Not able to void in toilet (ex: requiring use of bed pan to void)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

17 participants in 2 patient groups, including a placebo group

Peppermint Oil
Experimental group
Description:
Subjects will be exposed to vapor of peppermint oil
Treatment:
Other: Peppermint oil vapors
Placebo
Placebo Comparator group
Description:
Subjects will be exposed to vapor of placebo (mineral oil)
Treatment:
Other: Mineral Oil

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems